Cramer’s lightning round: I’m sticking with Marvell Technology

Cramer’s lightning round: I’m sticking with Marvell Technology


Rocket Companies Inc: “I said the Fed was raising rates: you can’t own anything in that area. And the Fed is still raising, so you still can’t.”

Marvell Technology Inc: “It’s driving me bonkers that it could be doing so well and it’s stuck right here, down so much. But we’re sticking with it.”

Vertex Pharmaceuticals Inc: “I like it very much. … I just have been trying to figure out exactly whether that drug is going to be passed, and I don’t know the answer.”

Disclosure: Cramer’s Charitable Trust owns shares of Devon Energy and Marvell Technology.



Source

The cost to fly private is up as much as 20% with fuel prices soaring
Business

The cost to fly private is up as much as 20% with fuel prices soaring

A Gulfstream G-IV private jet on approach to Washington’s Reagan National Airport in Arlington, Virginia, June 12, 2024. J. David Ake | Getty Images As the Iran war pushes jet fuel prices higher, well-heeled travelers are facing hefty surcharges to fly private, sometimes on flights booked months prior, charter brokers and aviation insiders told CNBC. […]

Read More
United unveils basic Polaris business fare in premium cabin overhaul
Business

United unveils basic Polaris business fare in premium cabin overhaul

United Airlines new Polaris seat on one of its Boeing 787 Dreamliners Leslie Josephs/CNBC Does it matter where you sit if you’re sipping Champagne in first class? United Airlines is betting that for some travelers looking for luxury at a discount, it doesn’t. The carrier is launching new, cheaper tiers for its top-end Polaris and […]

Read More
Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs
Business

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

The Trump administration is preparing to impose new tariffs on branded drugs from pharmaceutical companies that have not struck landmark deals with the president to lower their U.S. drug prices, CNBC has learned.  Patented medications and their active ingredients would be hit with a 100% tariff, according to a draft of the document obtained by […]

Read More